IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RA Capital Management, L.P.

Q4 2018 Holdings

Filed 2019-02-14 | 25 holdings | $449.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Ascendis Pharma A S(ASND)SPONSORED ADR04351P101$265.7M4,240,53659.1%
Biocryst Pharmaceuticals(BCRX)COM09058V103$86.0M10,660,34919.1%
Crinetics Pharmaceuticals Inc(CRNX)COM22663K107$56.2M1,875,20912.5%
Arvinas Inc(ARVN)COM04335A105$40.3M3,138,4129.0%
Wave Life Sciences LTD(WVE)SHSY95308105$315.8K7,512,0490.1%
Synthorx IncCOM87167A103$169.0K9,724,5980.0%
Zogenix IncCOM NEW98978L204$86.9K2,382,1680.0%
Orchard Therapeutics PLCADS68570P101$76.2K4,845,9330.0%
Inflarx NV(IFRX)COMN44821101$75.8K2,085,0890.0%
Solid Biosciences IncCOM83422E105$72.1K2,689,4440.0%
Myovant Sciences LTDCOMG637AM102$60.9K3,711,5490.0%
Eidos Therapeutics Inc(EIDXGBP)COM28249H104$59.2K2,162,6710.0%
Rhythm Pharmaceuticals Inc(RYTM)COM76243J105$52.4K1,950,3320.0%
Immunomedics Inc(IMMU)COM452907108$43.1K3,021,4660.0%
RA Pharmaceuticals IncCOM74933V108$34.0K4,858,2600.0%
TG Therapeutics Inc(TGTX)COM88322Q108$33.6K8,198,3370.0%
Kalvista Pharmaceuticals Inc(KALV)COM483497103$28.5K1,441,0700.0%
Momenta Pharmaceuticals Inc(MNTA)COM60877T100$28.2K2,558,3570.0%
Dicerna Pharmaceuticals Inc(DRNAUSD)COM253031108$26.3K2,456,6690.0%
Eiger Biopharmaceuticals Inc(CLDNEUR)COM28249U105$24.5K2,415,4580.0%
Iovance Biotherapeutics Inc(IOVA)COM462260100$24.1K2,720,4520.0%
Moderna Inc(MRNA)COM60770K107$23.1K1,514,3260.0%
Kala Pharmaceuticals IncCOM483119103$22.2K4,537,4780.0%
Scpharmaceuticals Inc(SCPH)COM810648105$10.7K2,857,1430.0%
Proteon Therapeutics IncCOM74371L109$3.0K1,337,4620.0%